A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics
Public ClinicalTrials.gov record NCT04663282. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation of the Efficacy and Safety of INS068 Injection and Insulin Degludec Subcutaneous Injection Once Daily in Subjects With Type 2 Diabetes Mellitus Not Adequately Controlled With One or Two Oral Antidiabetics (A Randomized, Open-Label, Two-Arm, Treat-to-Target, Parallel Controlled Trial)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is being conducted to evaluate the efficacy and safety of IND068 once daily (QD) in subjects with type 2 diabetes not adequately controlled with one or two oral antidiabetics compared to insulin degludec QD for 16 weeks.
Study identification
- NCT ID
- NCT04663282
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 179 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 4, 2021 (Actual)
- Primary completion
- May 28, 2022 (Actual)
- Completion
- May 28, 2022 (Actual)
- Last update posted
- Dec 21, 2022
2021 – 2022
United States locations
- U.S. sites
- 15
- U.S. states
- 5
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| National Research Institute - Huntington Park | Huntington Park | California | 90255 | — |
| Clinical Trials Research | Lincoln | California | 95648 | — |
| Torrance Clinical Research Institute Inc | Lomita | California | 90717 | — |
| National Research Institute - Wilshire | Los Angeles | California | 90057 | — |
| ALL Medical Research, LLC | Cooper City | Florida | 33024 | — |
| New Generation of Medical Research | Hialeah | Florida | 33016 | — |
| Clinical Pharmacology of Miami, LLC | Miami | Florida | 33014-3616 | — |
| Progressive Medical Research | Port Orange | Florida | 32127 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50265 | — |
| Endocrinology Associates, Inc | Columbus | Ohio | 43201 | — |
| Prestige Clinical Research | Franklin | Ohio | 45005 | — |
| Juno Research, LL | Houston | Texas | 77040 | — |
| Juno Research, LLC - Medical Center Office | Houston | Texas | 77054 | — |
| Juno Research, LLC - Southwest Houston Site | Houston | Texas | 77074 | — |
| Endeavor Clinical Trials | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04663282, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 21, 2022 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04663282 live on ClinicalTrials.gov.